Objective: Anemia and operative blood loss are common in the elderly, but evidence is lacking on whether intraoperative blood transfusions can reduce the risk of postoperative death. Methods: We analyzed retrospective data from 239,286 patients 65 years of older who underwent major noncardiac surgery in 1997 to 2004 at veteran hospitals nationwide. Propensity-score matching was used to adjust for differences between patients who received intraoperative blood transfusions (9.4%) and those who did not, and data were used to determine the association between intraoperative blood transfusion and 30-day postoperative mortality. Results: After propensity-score matching, intraoperative blood transfusion was associated with mortality risk reductions in patients with preoperative hematocrit levels of Ͻ24% (odds ratio: 0.60, 95% CI: 0.41-0.87), and in patients with hematocrit of 30% or greater when there is substantial (500 -999 mL) blood loss (odds ratio: 0.35, 95% CI: 0.22-0.56 for hematocrit levels between 30%-35.9% and 0.78, 95% CI: 0.62-0.97 for hematocrit levels of 36% or greater). When operative blood loss was Ͻ500 mL, transfusion was not associated with mortality reductions for patients with hematocrit levels of 24% or greater, and conferred increased mortality risks in patients with preoperative hematocrit levels between 30% to 35.9% (odds ratio 1.29, 95% CI: 1.04 -1.60). Conclusions: Intraoperative blood transfusion is associated with a lower 30-day postoperative mortality among elderly patients undergoing major noncardiac surgery if there is substantial operative blood loss or low preoperative hematocrit levels (Ͻ24%). Transfusion is associated with increased mortality risks for those with preoperative hematocrit levels between 30% and 35.9% and Ͻ500 mL of blood loss.
B oth anemia and blood loss are common risk factors for mortality in patients undergoing surgery [1] [2] [3] ; yet, the benefits and the hematocrit trigger at which intraoperative blood transfusion should be given to treat anemia and blood loss are still unknown. While rigorous investigations have examined the optimal hematocrit range at which transfusion is beneficial in intensive care and coronary care unit settings, 4, 5 similar studies in surgery are lacking. Available reports are limited by small samples and/or single surgical specialties, 6, 7 and have not documented efficacy of surgical blood transfusion. Indeed, various small sample studies reported intraoperative blood use to be either ineffective to improve postoperative outcomes, 8 or found it to be detrimental. 9, 10 Current recommendations on perioperative blood transfusion are mostly based on expert consensus, and not controlled studies. 11, 12 Elderly patients undergoing surgery are particularly vulnerable to blood loss and anemia's adverse effects, since they have limited physiological reserve, 13, 14 and a high prevalence of underlying coronary disease. 15 As a result, patients greater than 65 years of age receive nearly half of all blood transfusions, 16 while evidence is lacking in its use in the operating room. Limited evidence complicates the transfusion decision, and is 1 source of the great variability in transfusion practices in the operating room with large impact in cost and quality of care. 17, 18 To this effect, the current study analyzes a nationwide cohort of war veteran patients, older than age 65 years, who underwent major noncardiac surgery to determine the effect of intraoperative blood transfusion on 30-day postoperative mortality.
METHODS
The institutional review boards at the Providence VA Medical Center, VA Boston Healthcare System and the University of Colorado Multiple (COMIRB) sites approved the study. We analyzed retrospective cohort data from the Department of Veterans Affairs (VA) National Surgical Quality Improvement Program (NSQIP), which has been described in detail. 19 Briefly, NSQIP is a VA-wide initiative to improve surgical care through prospective collection of data on patient risk for major surgery and report of risk-adjusted postoperative outcomes. 20, 21 It includes the major procedures (defined as performed in the operating room that required general, spinal, or epidural anesthesia) in 8 surgical subspecialties (general surgery, vascular surgery, orthopedics, urology, noncardiac thoracic surgery, neurosurgery, otolaryngology, and plastic surgery) from 132 VA hospitals since 1991. Excluded were repeated operations on patients entered into the dataset in the previous 30 days, and surgical procedures with very low morbidity and mortality, such as ophthalmology, auditory, or nasal procedures. Nurse reviewers in each participating center extracted the data, with periodic reabstraction of the data by external reviewers showing very good agreement. The NSQIP dataset can be merged with other VA datasets to obtain additional information. In this study, the NSQIP dataset was merged with the VA Patient Treatment Files to obtain records on the use of autologous transfusions and prior hospitalizations related to coronary artery disease, and to the Outpatient Care files to identify patients with cell saver procedure within 30 days prior to surgery and those with stable coronary artery disease treated in the ambulatory setting.
Analytic Sample
The analytic cohort was war veteran patients aged 65 years or older with a documented preoperative hematocrit value who underwent major noncardiac surgery during years 1997 to 2004 (310,311 cases). Random selection restricted those patients with multiple operations during the study period to 1 case per patient (70,506 cases excluded). We excluded 12 patients with missing transfusion information and 507 patients with preoperative hematocrit levels of 54% or greater, for a final analytic sample of 239,286 patients.
Preoperative Hematocrit Values
Preoperative hematocrit was defined as the last hematocrit measurement prior to the index operation. The median duration between the last hematocrit measurement and the index operation is 3 days with an interquartile range of 1 to 11 days. Based on previous work, 1 preoperative hematocrit values were stratified a priori into 4 categories: Ͻ24%, 24% to 29.9%, 30% to 35.9%, and 36% or greater, to detect the pretransfusion hematocrit threshold at which intraoperative blood use might be associated with postoperative outcomes.
Intraoperative Blood Transfusion
Patients were classified as having received intraoperative blood transfusions if they received whole blood or packed red blood cells during their procedure. Although this definition included blood transfused to the patient collected from a cell saver, only 113 patients had an intraoperative autologous transfusion (2 patients within the 24%-29.9% preoperative hematocrit category, 26 patients within the 30%-35.9% hematocrit category and 85 patients within the 36%-53.9% hematocrit category).
Estimated Intraoperative Blood Loss
Intraoperative blood loss was calculated based on a modification of the formula of allowable blood loss by Drs. Gross 22 and Hahn 23 adapted to a population of predominantly male, elderly veterans 65 years or older, with variable perioperative blood volume shifts (as opposed to a constant proposed by the equations), taking into account intraoperative blood transfusions. To derive an equation suitable to our study sample, we used blood loss data (per anesthesiologist and/or surgeon) that was collected from the surgical package records of 71,232 veteran patients 65 years or older who underwent similar major noncardiac surgeries during October 1991 to August 1995 (data no longer collected in the NSQIP thereafter). Based on this earlier blood loss data, we were able to derive an equation to estimate intraoperative blood loss based on preoperative and postoperative hematocrit levels, while accounting for packed blood cells transfused during surgery: This equation showed a very good prediction of the recorded blood loss (r 2 ϭ 0.62).
Postoperative Outcome
Chart abstraction indicated death and postoperative complications within 30 days of the index surgery, with complete 30-day postoperative follow-up.
Statistical Analysis
We compared demographic and clinical characteristics of patients who received intraoperative blood transfusion and those who did not to identify potential confounders. 2 analyses for categorical variable and t-tests for continuous variables tested differences between groups.
Propensity analysis was used to match patients for comparison of 30-day postoperative mortality rates between transfused and those not transfused intraoperatively. 24 A nonparsimonious logistic regression model estimated a propensity score for the presence of intraoperative blood transfusions. The model included the patient's preoperative demographic and clinical characteristics, hospital of the surgery, postgraduate year and surgical subspecialty of the surgeon, complexity of the surgery as determined by relative value units, 25 and the 4 preoperative hematocrit categories. An indicator variable denoted whether a complication occurred on the day of surgery or first postoperative day to account for a complicated procedure. The resulting logistic regression computed each patient's probability of intraoperative blood transfusion. Patients who received intraoperative blood transfusion were matched 1:1 to those who did not, based on the propensity for transfusion and the year of surgery. 26 We then examined the matched cohort for balance of baseline characteristics between the transfused and the nontransfused groups. Conditional logistic regression determined the effect of intraoperative blood transfusion on 30-day postoperative mortality risk, adjusting for residual differences. Since the effects of intraoperative blood transfusion might vary by the severity of anemia and bleeding, the association between blood transfusion and 30-day postoperative mortality was examined in the 4 preoperative hematocrit subgroups in the propensity-matched cohort, stratified by estimated intraoperative blood loss (less than 500 mL, 500 -999 mL, and 1000 mL or greater). 3 
RESULTS
The analytic sample included 239,286 patients; 9.4% received at least 1 unit of red blood cells during surgery. For both the transfused and the nontransfused patients, 98% were male, with an average age of 73 years ( Table 1 ). The rate of intraoperative blood transfusion decreased as preoperative hematocrit values increased, from 54.5% among patients with a preoperative hematocrit level of Ͻ24% to 5.8% in patients with a preoperative hematocrit value of 36% or greater. Transfused patients tended to have lower preoperative hematocrit values, were less likely to be white, and had a higher prevalence of severe systemic disease (American Society of Anesthesiologists class 4 or 5), cardiac disease (eg, congestive heart failure, myocardial infarction), neurologic disorder (eg, cerebrovascular disease, coma), pulmonary disorder (eg, obstructive pulmonary disease, ventilator dependence), hematologic problems (eg, bleeding, preoperative blood use greater than 4 units), ascites and renal failure. Patients who received intraoperative blood transfusions were also more likely to have more complex and lengthy surgical procedures, to undergo emergency surgery, vascular surgery and general anesthesia, and have morbidity within the first postoperative day ( Table 1; and Expanded Table 1 , Supplemental Digital Content 1, online only, Available at: http://links.lww.com/SLA/A49). They were also more likely to have abnormal preoperative laboratory values, transferred from another hospital or nursing home and operated on in hospitals with higher average surgical case loads per year (Expanded Table 1 , online only).
In generating the propensity score for intraoperative blood transfusion, the logistic regression model had excellent predictive discrimination, with a c-index of 0.883. Based on the propensity score, 83% of transfused patients (n ϭ 18,646) were matched with nontransfused controls (n ϭ 18,646). Transfused patients received an average of 2.6 units of red blood cells intraoperatively. Examination of this matched cohort ( Table 2; and Expanded Table 2 , Supplemental Digital Content 2, online only, available at: http://links.lww.com/SLA/A50) showed successful matching, with balance of almost all the baseline characteristics between the transfused and nontransfused patients. Only 3 of 58 variables had clinically and statistically significant imbalance between the transfused and nontransfused matched-samples: mean operative time (3.8 vs. 2.8 hours), proportion of American Society of Anesthesiologist class 5 patients (1.5% vs. 1.0%), and rate of general anesthesia use (89.3% vs. 80%).
Analysis of the propensity-matched cohort showed 30-day postoperative mortality rate to be higher in transfused (10.5%) as compared with nontransfused patients (8.6%). After adjusting for mean operative time, ASA classification, and the rate of general anesthesia with conditional logistic regression, transfused patients were at increased risk for 30-day postoperative mortality compared with nontransfused counterparts (adjusted odds ratio: 1.37, 95% CI: 1.27-1.48). However, subgroup analyses of the matched cohort found that risk to vary according to preoperative hematocrit levels and the amount of operative blood loss ( Fig. 1) . Intraoperative blood transfusion conferred a reduced 30-day postoperative mortality risk in patients with a preoperative hematocrit value less than 24% (odds ratio: 0.60, 95% CI: 0.41-0.87) overall; and no significant change in mortality risks in patients with a preoperative hematocrit value between 24% and 29.9% (odds ratio: 1.04, 95% CI: 0.91-1.20), although all but 6 nontransfused patients in this hematocrit category had an operative blood loss of less than 500 mL. Among patients with preoperative hematocrit values of 30% and more, intraoperative blood transfusion was associated with reduced 30-day postoperative mortality risks when there was substantial blood loss of 500 to 999 mL (odds ratio: 0.35, 95% CI: 0.22-0.56 for hematocrit levels between 30%-35.9% and 0.78, 95% CI: 0.62-0.97 for hematocrit levels of 36% or greater), with no change in risk or possibility of harm when blood loss is less than 500 mL (odds ratio: 1.29, 95% CI: 1.04 -1.60 for hematocrit levels between 30% and 35.9%; and 1.40, 95% CI: 0.68 -2.88 for hematocrit levels of 36% or greater). There were 6393 (18%) patients with an operative blood loss of 1000 mL or greater, of which only 6 patients were not transfused intraoperatively, and all of them had preoperative hematocrit levels of 30% and greater. Mortality rates were 10.2% for the transfused patients and 16.7% for the nontransfused (P ϭ nonsignificant).
Analyses of late postoperative complications (after day 1) among the deceased patients showed an overall higher incidence of postoperative respiratory complications (failure to wean from ventilator, unplanned intubation) and sepsis, and to a smaller degree, postoperative renal failure, and bleeding among those who received intraoperative blood transfusions compared with those who were not transfused ( Table 3 ).
DISCUSSION
Although preoperative anemia and operative blood loss are both associated with increased morbidity and mortality in elderly patients undergoing major noncardiac surgery, 1-3 there is limited evidence on treatment of perioperative anemia and blood loss with intraoperative blood transfusions. Our findings suggest that the association between intraoperative blood transfusion and 30-day *Emergency surgery is considered to exist when the anesthesiologist and the attending surgeon document a case to be "emergent" in the anesthesia record and the operative report. Surgical morbidity included cardiac arrest, myocardial infarction, stroke, coma, graft or prosthetic failure, sepsis, pneumonia, unplanned intubation or failure to wean from ventilator, pulmonary embolism or deep venous thrombosis, urinary tract infection, renal failure, wound infection, and bleeding.
COPD indicates chronic obstructive pulmonary disease; CVA, cerebrovascular accident. postoperative mortality depends substantially on preoperative hematocrit levels and intraoperative blood loss. Intraoperative blood transfusion conferred a reduced 30-day postoperative mortality risk in patients with a preoperative hematocrit value less than 24%, and no significant change in mortality risks when preoperative hematocrit levels are between 24% and 29.9%. At higher preoperative hematocrit levels of 30% or greater, intraoperative blood transfusion conferred reduced 30-day postoperative mortality risks when there is substantial blood loss of 500 to 999 mL, and no change in risk or potential for harm when blood loss is less than 500 mL. The relationship between perioperative anemia and postoperative adverse events has been described in several reports. Wu et al found a 1.6% increase in 30-day postoperative risk of death for every preoperative hematocrit point below 39% in a cohort of elderly veteran patients 65 years or older undergoing major noncardiac surgery. 1 In patients undergoing vascular surgery or radical prostatectomy, postoperative hematocrit levels below 28% were found to be associated with intraoperative and postoperative cardiac morbidity and ischemic events. 27, 28 Carson et al found both preoperative and postoperative anemia to be related to postoperative death, especially in patients with cardiovascular diseases. 2 In addition, perioperative anemia can be worsened by operative blood loss. Studies have shown an interaction between hemoglobin levels and surgical blood loss on postoperative outcomes. 2 Both Carson and Spence and their respective coauthors found an increased hospital mortality for those patients whose operative blood loss exceeds 500 mL. 3, 29 These studies suggest that both perioperative anemia and operative blood loss are risk factors for adverse postoperative outcomes. Consistent with this rationale, the current study found that the use of intraoperative blood transfusion in the treatment of anemia was related to reduced mortality in older patients with preoperative hematocrit levels of less than 24% and those with higher hematocrit values who experienced substantial intraoperative blood losses (500 -999 mL).
However, blood transfusion has its risks, including transmission of blood-borne pathogens, 30 hemolytic reactions, acute lung injury, volume overload, and immunosuppression, among others. 31 Thus, in patients with lesser degrees of anemia or blood loss, the potential adverse effects of transfusion might balance against, and in some cases, outweigh its benefits. The current study found no significant mortality benefits of intraoperative blood transfusion for patients with operative blood loss of Ͻ500 mL when their preoperative hematocrit levels were 24% or greater, and a potential for harm among patients with hematocrit levels of 30% to 35.9%. Comparable to our results, elderly patients undergoing hip surgery with hemoglobin values of 8 to 9 g/dL (approximately equal to hematocrit levels of 24%-27% in our study) also appear to experience no mortality benefit from blood transfusions. 6, 32 Other cohort studies have suggested that blood transfusion in patients with only mild to no anemia might increase mortality. In a national cohort of elderly patients with acute myocardial infarction without documented bleeding, blood transfusion use was not beneficial in patients with hematocrit levels Ͼ33% and associated with an increased 30-day mortality when hematocrit levels were greater than 36%. 5 Perioperative red blood cell use in cardiac surgery has also been observed to increase postoperative mortality and complications. 9,10 Analyses of postoperative complication rates among deceased patients in our sample suggest that the potential causes for the higher risk of death among transfused patients with hematocrit levels of 30% to 35.9% versus nontransfused patients are multifactorial. The significantly higher respiratory complication rates and a trend toward higher sepsis rates among the transfused patients compared with the nontransfused suggest a greater role for hypervolemia, lung injury, and Surgical morbidity that occurred within postoperative d 1 (%)* 5.6 5.6 0.857 *Emergency surgery is considered to exist when the anesthesiologist and the attending surgeon document a case to be "emergent" in the anesthesia record and the operative report. Surgical morbidity included cardiac arrest, myocardial infarction, stroke, coma, graft or prosthetic failure, sepsis, pneumonia, unplanned intubation or failure to wean from ventilator, pulmonary embolism or deep venous thrombosis, urinary tract infection, renal failure, wound infection, and bleeding.
COPD indicates Chronic obstructive pulmonary disease; CVA, Cerebrovascular accident.
immunosuppression than the other potential sources. Further studies are needed to validate this observation. The NIH Consensus Statement on Perioperative Red Cell Transfusion and the American Society of Anesthesiologists practice guidelines suggest that red blood cell transfusion is usually indicated in perioperative patients with hemoglobin values of 6 to 7 g/dL or less and is rarely indicated in patients with hemoglobin values greater than 10 g/dL, while leaving an uncertain gap between hemoglobin values of 7 to 10 g/dL. 11, 12 Additionally, there is no information on how blood loss may change the need for transfusion. Our findings inform future recommendations by showing mortality risk reductions associated with transfusion in patients with preoperative hematocrit levels of Ͻ24% (approximately a hemoglobin of 8 g/dL), or in patients with mild to no preoperative anemia (hematocrit of 30% or greater) when there is substantial blood loss (500 -999 mL). They also confirm that intraoperative transfusion is not helpful for patients with hematocrit levels of 24% or greater, when the estimated blood loss was Ͻ500 mL. This is important since red blood cell transfusions also represent a substantial financial burden to healthcare, with each unit of blood from acquisition to transfusion costing approximately $1600 to $2400 US dollars. 33 This study has several limitations and strengths. First, the study sample is mostly male, so results may not generalize to the older female 1 . Association between intraoperative blood transfusion and 30-day postoperative mortality in the propensity matched dataset stratified by preoperative hematocrit and intraoperative blood loss. There were 6393 patients with an operative blood loss of 1000 mL or greater, of which only 6 patients were not transfused intraoperatively; hence data was not included in the figure. All of them had preoperative hematocrit levels of 30% and greater. There were 1949 patients (5%) of the entire propensity matched cohort not included in the subanalysis based on intraoperative blood loss due to lack of postoperative hematocrit data. HCT indicates hematocrit.
Annals of Surgery • Volume 252, Number 1, July 2010 Blood Loss and Transfusion in Surgery population undergoing major noncardiac surgery. This is especially important given gender differences in preoperative hematocrit levels, blood volume and pattern of blood transfusion, showing women in general to have lower preoperative hematocrit levels and smaller blood volume, and receive more intraoperative blood transfusions than men. 34 -36 Gender differences in blood transfusion persisted even after controlling for age, weight (accounting for blood volume), duration of surgery, and preoperative hematocrit levels. 36 Future studies are needed to address the blood transfusion needs of women during surgery and whether gender differences in transfusion pattern may relate to postoperative outcomes. Second, we do not have information on the chronicity of anemia, the age of the transfused blood, or information on whether the blood was leukodepleted. Third, blood transfusion during surgery was not randomly assigned and therefore, the results may be confounded by indications for blood transfusion. Although state-of-the-art propensity methods matched patients on a broad spectrum of clinical characteristics, residual confounding may still exist. Fourth, the blood loss variable is not directly captured, but only an estimate based on blood transfused during surgery and the difference between the preoperative and nadir postoperative hematocrit levels. Since hematocrit is a volume-based measure, volume shifts in the perioperative period, which can range from dehydration to hypervolemia due to different clinical scenarios (eg, preoperative fasting, intravenous fluid replacements, postoperative diuresis), are likely to change the precision of the estimates. In addition, the timing of postoperative hematocrit measurement (not standardized) might also limit the precision of the estimated blood loss equation, since surgical blood loss would be underestimated if any postoperative blood transfusion should occur before the postoperative hematocrit is drawn. Therefore, although this equation showed a very good prediction against the recorded blood loss at the population level, it should be interpreted with caution when applied to individual patients, since it was not validated against other methods of blood loss estimation such as suction losses, sponge weights, or others. Lastly, our study would not be applicable to specific situations in which cell saver and autologous blood transfusions are commonly used. Nonetheless, this study's strengths are its large, nationwide sample, comprehensive and reliable data extraction, and breadth of procedures and patients with diverse coexisting morbidities. Among elderly patients who underwent major noncardiac surgery, intraoperative blood transfusion was associated with mortality risk reductions in patients with preoperative hematocrit levels of Ͻ24%, or in patients with mild to no preoperative anemia (hematocrit of 30% or greater) when there is substantial blood loss (500 -999 mL). Intraoperative transfusion is not helpful for patients with hematocrit levels of 24% or greater when the estimated blood loss was Ͻ500 mL, and it may be harmful if their preoperative hematocrit levels were between 30% to 35.9%. Ideally, randomizedcontrolled trials would confirm these findings, but such trials would be difficult to design, and providers and patients may be unwilling to randomize or be randomized. Until such trial can be mounted, this study's findings provide some of the best evidence to date to guide blood use in the operative setting.
